In continuation to letter dated November 14, 2025 and pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Emcure Pharmaceuticals has informed that it enclosed a copy of the Investor Presentation that would form part of the discussions during the Investor Conferences, to be attended by Officials of the Company, on November 19, 2025 and November 20, 2025. The same is also available on the Company’s website: www.emcure.com.
The above information is a part of company’s filings submitted to BSE.
